UK markets close in 37 minutes

Advanced Medical Solutions Group plc (AMS.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
216.49-1.51 (-0.69%)
As of 03:30PM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 467.19M
Enterprise value 416.17M
Trailing P/E 30.07
Forward P/E 22.94
PEG ratio (5-yr expected) 4.80
Price/sales (ttm)3.79
Price/book (mrq)1.91
Enterprise value/revenue 3.30
Enterprise value/EBITDA 12.87

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3-10.47%
S&P500 52-week change 322.49%
52-week high 3261.00
52-week low 3165.60
50-day moving average 3199.81
200-day moving average 3201.13

Share statistics

Avg vol (3-month) 3684.04k
Avg vol (10-day) 3376.9k
Shares outstanding 5214.31M
Implied shares outstanding 6217.26M
Float 8178.2M
% held by insiders 12.62%
% held by institutions 165.82%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.02
Forward annual dividend yield 41.08%
Trailing annual dividend rate 30.02
Trailing annual dividend yield 30.01%
5-year average dividend yield 40.72
Payout ratio 430.48%
Dividend date 3N/A
Ex-dividend date 430 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 12.59%
Operating margin (ttm)13.11%

Management effectiveness

Return on assets (ttm)4.14%
Return on equity (ttm)6.61%

Income statement

Revenue (ttm)126.21M
Revenue per share (ttm)0.58
Quarterly revenue growth (yoy)-4.40%
Gross profit (ttm)N/A
EBITDA 26.6M
Net income avi to common (ttm)15.89M
Diluted EPS (ttm)0.07
Quarterly earnings growth (yoy)-35.20%

Balance sheet

Total cash (mrq)60.16M
Total cash per share (mrq)0.28
Total debt (mrq)9.14M
Total debt/equity (mrq)3.74%
Current ratio (mrq)5.67
Book value per share (mrq)1.14

Cash flow statement

Operating cash flow (ttm)12.35M
Levered free cash flow (ttm)1.7M